| 1. |
Wakisaka Y, Matsuo R, Kuroda J, Ago T, Kamouchi M, Kitazono T, Influence of pre-stroke cholinesterase inhibitor treatment on short-term functional outcome in acute ischemic stroke patients with pre-stroke dementia., 8th Korea-Japan Joint Stroke Conference, 2017.10. |
| 2. |
脇坂 義信, Pre-stroke dementia is associated with poor functional outcome after acute ischemic stroke: the Fukuoka Stroke Registry
, International Stroke Conference 2016, 2016.02. |
| 3. |
Yoshinobu Wakisaka, Extracellular newly identified receptor for advanced glycation end products binding protein (EN-RAGE) predicts the outcome in patients with acute ischemic stroke: Research for Biomarkers in Ischemic Stroke
, International Stroke Conference 2013, 2013.02, Background: Extracellular newly identified receptor for advanced glycation end products binding protein (EN-RAGE) contributes to inflammation and associates with poor outcome after ischemic heart disease. We assessed the plasma EN-RAGE levels in acute stroke patients and examined their relation with functional outcome after stroke.
Methods: Blood samples and clinical information were obtained from 171 patients with ischemic stroke at 5 points (days 0, 3, 7,14, and 90) after the onset. Age- and sex-matched healthy 171 controls were enrolled from the Hisayama study in Japan. Stroke severity was assessed with the National Institute of Health Stroke Score (NIHSS). Functional outcome at 90 days was assessed by modified Rankin scale (mRS). To analyze the effects of EN-RAGE levels on stroke severity and outcome, patients were divided into high and low EN-RAGE groups according to whether the level was above or below the median of the whole patients at day 0.
Results: EN-RAGE levels at day 0 were higher in patients [1.6 (0.8-3.5), median (IQR)] than in controls [0.9 (0.4-1.6)] (pConclusions: Our study suggests that EN-RAGE predicts poor outcome in patients with acute ischemic stroke.
. |
